-
1
-
-
0034778819
-
Population prevalence, incidence, and predictors of atrial fibrillation in the renfrew/paisley study
-
Stewart S, Hart CL, Hole DJ, McMurray JJ. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart. 2001;86:516-521.
-
(2001)
Heart
, vol.86
, pp. 516-521
-
-
Stewart, S.1
Hart, C.L.2
Hole, D.J.3
McMurray, J.J.4
-
2
-
-
0035832261
-
Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The anticoagulation and risk factors in atrial fibrillation (atria) study
-
Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370-2375.
-
(2001)
JAMA
, vol.285
, pp. 2370-2375
-
-
Go, A.S.1
Hylek, E.M.2
Phillips, K.A.3
Chang, Y.4
Henault, L.E.5
Selby, J.V.6
Singer, D.E.7
-
3
-
-
33747052359
-
Secular trends in incidence of atrial fibrillation in olmsted county, minnesota, 1980 to 2000, and implications on the projections for future prevalence
-
Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Seward JB, Tsang TS. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114:119-125.
-
(2006)
Circulation
, vol.114
, pp. 119-125
-
-
Miyasaka, Y.1
Barnes, M.E.2
Gersh, B.J.3
Cha, S.S.4
Bailey, K.R.5
Abhayaratna, W.P.6
Seward, J.B.7
Tsang, T.S.8
-
4
-
-
36248929793
-
Outcome parameters for trials in atrial fibrillation: Executive summary
-
Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener HC, Goette A, Hindricks G, Hohnloser S, Kappenberger L, Kuck KH, Lip GY, Olsson B, Meinertz T, Priori S, Ravens U, Steinbeck G, Svernhage E, Tijssen J, Vincent A, Breithardt G. Outcome parameters for trials in atrial fibrillation: executive summary. Eur Heart J. 2007;28:2803-2817.
-
(2007)
Eur Heart J
, vol.28
, pp. 2803-2817
-
-
Kirchhof, P.1
Auricchio, A.2
Bax, J.3
Crijns, H.4
Camm, J.5
Diener, H.C.6
Goette, A.7
Hindricks, G.8
Hohnloser, S.9
Kappenberger, L.10
Kuck, K.H.11
Lip, G.Y.12
Olsson, B.13
Meinertz, T.14
Priori, S.15
Ravens, U.16
Steinbeck, G.17
Svernhage, E.18
Tijssen, J.19
Vincent, A.20
Breithardt, G.21
more..
-
5
-
-
0025779484
-
Atrial fibrillation as an independent risk factor for stroke: The framingham study
-
Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983-988.
-
(1991)
Stroke
, vol.22
, pp. 983-988
-
-
Wolf, P.A.1
Abbott, R.D.2
Kannel, W.B.3
-
6
-
-
84995360016
-
European heart survey investigators. Atrial fibrillation management: A prospective survey in esc member countries: The euro heart survey on atrial fibrillation
-
Nieuwlaat R, Capucci A, Camm AJ, Olsson SB, Andresen D, Davies DW, Cobbe S, Breithardt G, Le Heuzey JY, Prins MH, Lévy S, Crijns HJ; European Heart Survey Investigators. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J. 2005;26:2422-2434.
-
(2005)
Eur Heart J
, vol.26
, pp. 2422-2434
-
-
Nieuwlaat, R.1
Capucci, A.2
Camm, A.J.3
Olsson, S.B.4
Andresen, D.5
Davies, D.W.6
Cobbe, S.7
Breithardt, G.8
Le Heuzey, J.Y.9
Prins, M.H.10
Lévy, S.11
Crijns, H.J.12
-
7
-
-
65249163311
-
The registry of the german competence network on atrial fibrillation: Patient characteristics and initial management
-
Nabauer M, Gerth A, Limbourg T, Schneider S, Oeff M, Kirchhof P, Goette A, Lewalter T, Ravens U, Meinertz T, Breithardt G, Steinbeck G. The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Europace. 2009;11:423-434.
-
(2009)
Europace
, vol.11
, pp. 423-434
-
-
Nabauer, M.1
Gerth, A.2
Limbourg, T.3
Schneider, S.4
Oeff, M.5
Kirchhof, P.6
Goette, A.7
Lewalter, T.8
Ravens, U.9
Meinertz, T.10
Breithardt, G.11
Steinbeck, G.12
-
8
-
-
77957930169
-
Stent thrombosis
-
Holmes DR Jr., Kereiakes DJ, Garg S, Serruys PW, Dehmer GJ, Ellis SG, Williams DO, Kimura T, Moliterno DJ. Stent thrombosis. J Am Coll Cardiol. 2010;56:1357-1365.
-
(2010)
J Am Coll Cardiol
, vol.56
, pp. 1357-1365
-
-
Holmes Jr., D.R.1
Kereiakes, D.J.2
Garg, S.3
Serruys, P.W.4
Dehmer, G.J.5
Ellis, S.G.6
Williams, D.O.7
Kimura, T.8
Moliterno, D.J.9
-
9
-
-
71749087343
-
Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin k antagonists in denmark: A retrospective analysis of nationwide registry data
-
Sorensen R, Hansen ML, Abildstrom SZ, Hvelplund A, Andersson C, Jorgensen C, Madsen JK, Hansen PR, Kober L, Torp-Pedersen C, Gislason GH. Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data. Lancet. 2009;374:1967-1974.
-
(2009)
Lancet
, vol.374
, pp. 1967-1974
-
-
Sorensen, R.1
Hansen, M.L.2
Abildstrom, S.Z.3
Hvelplund, A.4
Andersson, C.5
Jorgensen, C.6
Madsen, J.K.7
Hansen, P.R.8
Kober, L.9
Torp-Pedersen, C.10
Gislason, G.H.11
-
10
-
-
80052999262
-
Incidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiography
-
Kralev S, Schneider K, Lang S, Suselbeck T, Borggrefe M. Incidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiography. PLoS One. 2011;6:e24964.
-
(2011)
PLoS One
, vol.6
-
-
Kralev, S.1
Schneider, K.2
Lang, S.3
Suselbeck, T.4
Borggrefe, M.5
-
11
-
-
84885617087
-
Incidence, treatment, and outcomes of atrial fibrillation complicating non-st-segment elevation acute coronary syndromes
-
Lopes RD, White JA, Atar D, Keltai M, Kleiman NS, White HD, Widimsky P, Zeymer U, Giugliano RP, Tricoci P, Braunwald E, Bode C, Ohman EM, Armstrong PW, Newby LK. Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes. Int J Cardiol. 2013;168:2510-2517.
-
(2013)
Int J Cardiol
, vol.168
, pp. 2510-2517
-
-
Lopes, R.D.1
White, J.A.2
Atar, D.3
Keltai, M.4
Kleiman, N.S.5
White, H.D.6
Widimsky, P.7
Zeymer, U.8
Giugliano, R.P.9
Tricoci, P.10
Braunwald, E.11
Bode, C.12
Ohman, E.M.13
Armstrong, P.W.14
Newby, L.K.15
-
12
-
-
84884165644
-
Congestive heart failure and decongestion ability of two different treatments: Continuous renal replacement and diuretic therapy: Experience of a cardiac step down unit
-
Giglioli C, Spini V, Landi D, Chiostri M, Romano SM, Calabretta R, Gensini GF, Cecchi E. Congestive heart failure and decongestion ability of two different treatments: continuous renal replacement and diuretic therapy: experience of a cardiac step down unit. Acta Cardiol. 2013;68:355-364.
-
(2013)
Acta Cardiol
, vol.68
, pp. 355-364
-
-
Giglioli, C.1
Spini, V.2
Landi, D.3
Chiostri, M.4
Romano, S.M.5
Calabretta, R.6
Gensini, G.F.7
Cecchi, E.8
-
13
-
-
84862763541
-
Effect of new versus known versus no atrial fibrillation on 30-day and 10-year mortality in patients with acute coronary syndrome
-
Poci D, Hartford M, Karlsson T, Edvardsson N, Caidahl K. Effect of new versus known versus no atrial fibrillation on 30-day and 10-year mortality in patients with acute coronary syndrome. Am J Cardiol. 2012;110:217-221.
-
(2012)
Am J Cardiol
, vol.110
, pp. 217-221
-
-
Poci, D.1
Hartford, M.2
Karlsson, T.3
Edvardsson, N.4
Caidahl, K.5
-
14
-
-
83655167028
-
Incidence, predictors, and 30-day outcomes of new-onset atrial fibrillation after primary percutaneous coronary intervention: Insight into the risk-pci trial
-
Mrdovic I, Savic L, Krljanac G, Perunicic J, Asanin M, Lasica R, Antonijevic N, Kocev N, Marinkovic J, Vasiljevic Z, Ostojic M. Incidence, predictors, and 30-day outcomes of new-onset atrial fibrillation after primary percutaneous coronary intervention: insight into the RISK-PCI trial. Coron Artery Dis. 2012;23:1-8.
-
(2012)
Coron Artery Dis
, vol.23
, pp. 1-8
-
-
Mrdovic, I.1
Savic, L.2
Krljanac, G.3
Perunicic, J.4
Asanin, M.5
Lasica, R.6
Antonijevic, N.7
Kocev, N.8
Marinkovic, J.9
Vasiljevic, Z.10
Ostojic, M.11
-
15
-
-
46249109867
-
Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without st-segment elevation
-
Lopes RD, Pieper KS, Horton JR, Al-Khatib SM, Newby LK, Mehta RH, Van De Werf F, Armstrong PW, Mahaffey KW, Harrington RA, Ohman EM, White HD, Wallentin L, Granger CB. Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation. Heart. 2008;94:867-873.
-
(2008)
Heart
, vol.94
, pp. 867-873
-
-
Lopes, R.D.1
Pieper, K.S.2
Horton, J.R.3
Al-Khatib, S.M.4
Newby, L.K.5
Mehta, R.H.6
Van De Werf, F.7
Armstrong, P.W.8
Mahaffey, K.W.9
Harrington, R.A.10
Ohman, E.M.11
White, H.D.12
Wallentin, L.13
Granger, C.B.14
-
17
-
-
34347394385
-
Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
-
Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857-867.
-
(2007)
Ann Intern Med
, vol.146
, pp. 857-867
-
-
Hart, R.G.1
Pearce, L.A.2
Aguilar, M.I.3
-
18
-
-
33744945247
-
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (active w): A randomised controlled trial
-
ACTIVE Writing Group of the ACTIVE Investigators
-
ACTIVE Writing Group of the ACTIVE Investigators, Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, Chrolavicius S, Pfeffer M, Hohnloser S, Yusuf S. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet. 2006;367:1903-1912.
-
(2006)
Lancet
, vol.367
, pp. 1903-1912
-
-
Connolly, S.1
Pogue, J.2
Hart, R.3
Pfeffer, M.4
Hohnloser, S.5
Chrolavicius, S.6
Pfeffer, M.7
Hohnloser, S.8
Yusuf, S.9
-
19
-
-
84876862702
-
Risk of stroke or systemic embolism in atrial fibrillation patients treated with warfarin: A systematic review and meta-analysis
-
Albertsen IE, Rasmussen LH, Overvad TF, Graungaard T, Larsen TB, Lip GY. Risk of stroke or systemic embolism in atrial fibrillation patients treated with warfarin: a systematic review and meta-analysis. Stroke. 2013;44:1329-1336.
-
(2013)
Stroke
, vol.44
, pp. 1329-1336
-
-
Albertsen, I.E.1
Rasmussen, L.H.2
Overvad, T.F.3
Graungaard, T.4
Larsen, T.B.5
Lip, G.Y.6
-
20
-
-
0033593072
-
Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: The anticoagulation and risk factors in atrial fibrillation (atria) study
-
Go AS, Hylek EM, Borowsky LH, Phillips KA, Selby JV, Singer DE. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med. 1999;131:927-934.
-
(1999)
Ann Intern Med
, vol.131
, pp. 927-934
-
-
Go, A.S.1
Hylek, E.M.2
Borowsky, L.H.3
Phillips, K.A.4
Selby, J.V.5
Singer, D.E.6
-
21
-
-
80055083430
-
Net clinical benefit of adding clopidogrel to aspirin therapy in patients with atrial fibrillation for whom vitamin k antagonists are unsuitable
-
ACTIVE (Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events) Steering Committee and Investigators
-
Connolly SJ, Eikelboom JW, Ng J, Hirsh J, Yusuf S, Pogue J, de Caterina R, Hohnloser S, Hart RG; ACTIVE (Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events) Steering Committee and Investigators. Net clinical benefit of adding clopidogrel to aspirin therapy in patients with atrial fibrillation for whom vitamin K antagonists are unsuitable. Ann Intern Med. 2011;155:579-586.
-
(2011)
Ann Intern Med
, vol.155
, pp. 579-586
-
-
Connolly, S.J.1
Eikelboom, J.W.2
Ng, J.3
Hirsh, J.4
Yusuf, S.5
Pogue, J.6
De Caterina, R.7
Hohnloser, S.8
Hart, R.G.9
-
22
-
-
84868523625
-
2012 Focused update of the esc guidelines for the management of atrial fibrillation: An update of the 2010 esc guidelines for the management of atrial fibrillation. Developed with the special contribution of the european heart rhythm association
-
ESC Committee for Practice Guidelines (CPG
-
Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P; ESC Committee for Practice Guidelines (CPG). 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33:2719-2747.
-
(2012)
Eur Heart J
, vol.33
, pp. 2719-2747
-
-
Camm, A.J.1
Lip, G.Y.2
De Caterina, R.3
Savelieva, I.4
Atar, D.5
Hohnloser, S.H.6
Hindricks, G.7
Kirchhof, P.8
-
24
-
-
84869236631
-
Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: A systematic review and meta-analysis of the literature
-
Dentali F, Riva N, Crowther M, Turpie AG, Lip GY, Ageno W. Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature. Circulation. 2012;126:2381-2391.
-
(2012)
Circulation
, vol.126
, pp. 2381-2391
-
-
Dentali, F.1
Riva, N.2
Crowther, M.3
Turpie, A.G.4
Lip, G.Y.5
Ageno, W.6
-
25
-
-
84881477376
-
Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: A meta-analysis of 50,578 patients
-
Capodanno D, Capranzano P, Giacchi G, Calvi V, Tamburino C. Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: a meta-analysis of 50,578 patients. Int J Cardiol. 2013;167:1237-1241.
-
(2013)
Int J Cardiol
, vol.167
, pp. 1237-1241
-
-
Capodanno, D.1
Capranzano, P.2
Giacchi, G.3
Calvi, V.4
Tamburino, C.5
-
26
-
-
84885217467
-
2007 guidelines for the management of patients with unstable angina/non-st-elevation myocardial infarction: A report of the american college of cardiology foundation/american heart association task force on practice guidelines
-
American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA
-
Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr., Chavey WE II, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Jneid H, Ettinger SM, Ganiats TG, Lincoff AM, Philippides GJ, Zidar JP; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:e663-e828.
-
(2013)
Circulation
, vol.127
-
-
Anderson, J.L.1
Adams, C.D.2
Antman, E.M.3
Bridges, C.R.4
Califf, R.M.5
Casey Jr., D.E.6
Chavey II, W.E.7
Fesmire, F.M.8
Hochman, J.S.9
Levin, T.N.10
Lincoff, A.M.11
Peterson, E.D.12
Theroux, P.13
Wenger, N.K.14
Wright, R.S.15
Jneid, H.16
Ettinger, S.M.17
Ganiats, T.G.18
Lincoff, A.M.19
Philippides, G.J.20
Zidar, J.P.21
more..
-
27
-
-
84856158305
-
Esc committee for practice guidelines. Esc guidelines for the management of acute coronary syndromes in patients presenting without persistent st-segment elevation: The task force for the management of acute coronary syndromes (acs) in patients presenting without persistent st-segment elevation of the european society of cardiology (esc
-
Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, Ohman M, Petrie MC, Sonntag F, Uva MS, Storey RF, Wijns W, Zahger D; ESC Committee for Practice Guidelines. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:2999-3054.
-
(2011)
Eur Heart J
, vol.32
, pp. 2999-3054
-
-
Hamm, C.W.1
Bassand, J.P.2
Agewall, S.3
Bax, J.4
Boersma, E.5
Bueno, H.6
Caso, P.7
Dudek, D.8
Gielen, S.9
Huber, K.10
Ohman, M.11
Petrie, M.C.12
Sonntag, F.13
Uva, M.S.14
Storey, R.F.15
Wijns, W.16
Zahger, D.17
-
28
-
-
77958128969
-
Guidelines on myocardial revascularization
-
Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI
-
Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI), Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez- Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D. Guidelines on myocardial revascularization. Eur Heart J. 2010;31:2501-2555.
-
(2010)
Eur Heart J
, vol.31
, pp. 2501-2555
-
-
Wijns, W.1
Kolh, P.2
Danchin, N.3
Di Mario, C.4
Falk, V.5
Folliguet, T.6
Garg, S.7
Huber, K.8
James, S.9
Knuuti, J.10
Lopez- Sendon, J.11
Marco, J.12
Menicanti, L.13
Ostojic, M.14
Piepoli, M.F.15
Pirlet, C.16
Pomar, J.L.17
Reifart, N.18
Ribichini, F.L.19
Schalij, M.J.20
Sergeant, P.21
Serruys, P.W.22
Silber, S.23
Sousa Uva, M.24
Taggart, D.25
more..
-
29
-
-
83155180256
-
2011 Accf/aha/scai guideline for percutaneous coronary intervention: A report of the american college of cardiology foundation/american heart association task force on practice guidelines and the society for cardiovascular angiography and interventions
-
Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124:e574-e651.
-
(2011)
Circulation
, vol.124
-
-
Levine, G.N.1
Bates, E.R.2
Blankenship, J.C.3
Bailey, S.R.4
Bittl, J.A.5
Cercek, B.6
Chambers, C.E.7
Ellis, S.G.8
Guyton, R.A.9
Hollenberg, S.M.10
Khot, U.N.11
Lange, R.A.12
Mauri, L.13
Mehran, R.14
Moussa, I.D.15
Mukherjee, D.16
Nallamothu, B.K.17
Ting, H.H.18
-
30
-
-
0035899289
-
Clopidogrel in unstable angina to prevent recurrent events trial investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without st-segment elevation
-
Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK; Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494-502.
-
(2001)
N Engl J Med
, vol.345
, pp. 494-502
-
-
Yusuf, S.1
Zhao, F.2
Mehta, S.R.3
Chrolavicius, S.4
Tognoni, G.5
Fox, K.K.6
-
31
-
-
0037145863
-
Clopidogrel for the reduction of events during observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial
-
Steinhubl SR, Berger PB, Mann JT III, Fry ET, DeLago A, Wilmer C, Topol EJ; CREDO Investigators. Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002;288:2411-2420.
-
(2002)
JAMA
, vol.288
, pp. 2411-2420
-
-
Steinhubl, S.R.1
Berger, P.B.2
Mann III, J.T.3
Fry, E.T.4
DeLago, A.5
Wilmer, C.6
Topol, E.J.7
Credo, I.8
-
32
-
-
34047096264
-
Variability in individual responsiveness to clopidogrel: Clinical implications, management, and future perspectives
-
Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Alfonso F, Macaya C, Bass TA, Costa MA. Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives. J Am Coll Cardiol. 2007;49:1505-1516.
-
(2007)
J Am Coll Cardiol
, vol.49
, pp. 1505-1516
-
-
Angiolillo, D.J.1
Fernandez-Ortiz, A.2
Bernardo, E.3
Alfonso, F.4
Macaya, C.5
Bass, T.A.6
Costa, M.A.7
-
33
-
-
84880616993
-
Antiplatelet therapy: New pharmacological agents and changing paradigms
-
Capodanno D, Ferreiro JL, Angiolillo DJ. Antiplatelet therapy: new pharmacological agents and changing paradigms. J Thromb Haemost. 2013;11(suppl 1):316-329.
-
(2013)
J Thromb Haemost
, vol.11
, Issue.SUPPL. 1
, pp. 316-329
-
-
Capodanno, D.1
Ferreiro, J.L.2
Angiolillo, D.J.3
-
34
-
-
36148983750
-
Prasugrel versus clopidogrel in patients with acute coronary syndromes
-
TRITON-TIMI 38 Investigators
-
Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM; TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357:2001-2015.
-
(2007)
N Engl J Med
, vol.357
, pp. 2001-2015
-
-
Wiviott, S.D.1
Braunwald, E.2
McCabe, C.H.3
Montalescot, G.4
Ruzyllo, W.5
Gottlieb, S.6
Neumann, F.J.7
Ardissino, D.8
De Servi, S.9
Murphy, S.A.10
Riesmeyer, J.11
Weerakkody, G.12
Gibson, C.M.13
Antman, E.M.14
-
35
-
-
80052741598
-
Efficacy and safety of intensive antiplatelet therapy with prasugrel from triton-timi 38 in a core clinical cohort defined by worldwide regulatory agencies
-
Wiviott SD, Desai N, Murphy SA, Musumeci G, Ragosta M, Antman EM, Braunwald E. Efficacy and safety of intensive antiplatelet therapy with prasugrel from TRITON-TIMI 38 in a core clinical cohort defined by worldwide regulatory agencies. Am J Cardiol. 2011;108:905-911.
-
(2011)
Am J Cardiol
, vol.108
, pp. 905-911
-
-
Wiviott, S.D.1
Desai, N.2
Murphy, S.A.3
Musumeci, G.4
Ragosta, M.5
Antman, E.M.6
Braunwald, E.7
-
36
-
-
84867177857
-
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization
-
TRILOGY ACS Investigators
-
Roe MT, Armstrong PW, Fox KA, White HD, Prabhakaran D, Goodman SG, Cornel JH, Bhatt DL, Clemmensen P, Martinez F, Ardissino D, Nicolau JC, Boden WE, Gurbel PA, Ruzyllo W, Dalby AJ, McGuire DK, Leiva-Pons JL, Parkhomenko A, Gottlieb S, Topacio GO, Hamm C, Pavlides G, Goudev AR, Oto A, Tseng CD, Merkely B, Gasparovic V, Corbalan R, Cinteza M, McLendon RC, Winters KJ, Brown EB, Lokhnygina Y, Aylward PE, Huber K, Hochman JS, Ohman EM; TRILOGY ACS Investigators. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med. 2012;367:1297-1309.
-
(2012)
N Engl J Med
, vol.367
, pp. 1297-1309
-
-
Roe, M.T.1
Armstrong, P.W.2
Fox, K.A.3
White, H.D.4
Prabhakaran, D.5
Goodman, S.G.6
Cornel, J.H.7
Bhatt, D.L.8
Clemmensen, P.9
Martinez, F.10
Ardissino, D.11
Nicolau, J.C.12
Boden, W.E.13
Gurbel, P.A.14
Ruzyllo, W.15
Dalby, A.J.16
McGuire, D.K.17
Leiva-Pons, J.L.18
Parkhomenko, A.19
Gottlieb, S.20
Topacio, G.O.21
Hamm, C.22
Pavlides, G.23
Goudev, A.R.24
Oto, A.25
Tseng, C.D.26
Merkely, B.27
Gasparovic, V.28
Corbalan, R.29
Cinteza, M.30
McLendon, R.C.31
Winters, K.J.32
Brown, E.B.33
Lokhnygina, Y.34
Aylward, P.E.35
Huber, K.36
Hochman, J.S.37
Ohman, E.M.38
more..
-
37
-
-
70149101223
-
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
-
Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA, Freij A, Thorsén M; PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045-1057.
-
(2009)
N Engl J Med
, vol.361
, pp. 1045-1057
-
-
Wallentin, L.1
Becker, R.C.2
Budaj, A.3
Cannon, C.P.4
Emanuelsson, H.5
Held, C.6
Horrow, J.7
Husted, S.8
James, S.9
Katus, H.10
Mahaffey, K.W.11
Scirica, B.M.12
Skene, A.13
Steg, P.G.14
Storey, R.F.15
Harrington, R.A.16
Freij, A.17
Thorsén, M.18
Plato, I.19
-
38
-
-
79551563636
-
Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: Results from the plato (platelet inhibition and patient outcomes) trial
-
Held C, Asenblad N, Bassand JP, Becker RC, Cannon CP, Claeys MJ, Harrington RA, Horrow J, Husted S, James SK, Mahaffey KW, Nicolau JC, Scirica BM, Storey RF, Vintila M, Ycas J, Wallentin L. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. J Am Coll Cardiol. 2011;57:672-684.
-
(2011)
J Am Coll Cardiol
, vol.57
, pp. 672-684
-
-
Held, C.1
Asenblad, N.2
Bassand, J.P.3
Becker, R.C.4
Cannon, C.P.5
Claeys, M.J.6
Harrington, R.A.7
Horrow, J.8
Husted, S.9
James, S.K.10
Mahaffey, K.W.11
Nicolau, J.C.12
Scirica, B.M.13
Storey, R.F.14
Vintila, M.15
Ycas, J.16
Wallentin, L.17
-
39
-
-
17644388105
-
Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction
-
Buresly K, Eisenberg MJ, Zhang X, Pilote L. Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction. Arch Intern Med. 2005;165:784-789.
-
(2005)
Arch Intern Med
, vol.165
, pp. 784-789
-
-
Buresly, K.1
Eisenberg, M.J.2
Zhang, X.3
Pilote, L.4
-
40
-
-
71749087343
-
Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin k antagonists in denmark: A retrospective analysis of nationwide registry data
-
Sorensen R, Hansen ML, Abildstrom SZ, Hvelplund A, Andersson C, Jorgensen C, Madsen JK, Hansen PR, Kober L, Torp-Pedersen C, Gislason GH. Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data. Lancet. 2009;374:1967-1974.
-
(2009)
Lancet
, vol.374
, pp. 1967-1974
-
-
Sorensen, R.1
Hansen, M.L.2
Abildstrom, S.Z.3
Hvelplund, A.4
Andersson, C.5
Jorgensen, C.6
Madsen, J.K.7
Hansen, P.R.8
Kober, L.9
Torp-Pedersen, C.10
Gislason, G.H.11
-
41
-
-
84865863475
-
Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: A nationwide cohort study
-
Lamberts M, Olesen JB, Ruwald MH, Hansen CM, Karasoy D, Kristensen SL, Kober L, Torp-Pedersen C, Gislason GH, Hansen ML. Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study. Circulation. 2012;126:1185-1193.
-
(2012)
Circulation
, vol.126
, pp. 1185-1193
-
-
Lamberts, M.1
Olesen, J.B.2
Ruwald, M.H.3
Hansen, C.M.4
Karasoy, D.5
Kristensen, S.L.6
Kober, L.7
Torp-Pedersen, C.8
Gislason, G.H.9
Hansen, M.L.10
-
42
-
-
77956899158
-
Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation
-
Hansen ML, Sorensen R, Clausen MT, Fog-Petersen ML, Raunso J, Gadsboll N, Gislason GH, Folke F, Andersen SS, Schramm TK, Abildstrom SZ, Poulsen HE, Kober L, Torp-Pedersen C. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Arch Intern Med. 2010;170:1433-1441.
-
(2010)
Arch Intern Med
, vol.170
, pp. 1433-1441
-
-
Hansen, M.L.1
Sorensen, R.2
Clausen, M.T.3
Fog-Petersen, M.L.4
Raunso, J.5
Gadsboll, N.6
Gislason, G.H.7
Folke, F.8
Andersen, S.S.9
Schramm, T.K.10
Abildstrom, S.Z.11
Poulsen, H.E.12
Kober, L.13
Torp-Pedersen, C.14
-
43
-
-
84884479019
-
Ibaraki cardiovascular assessment study (icas) registry. Triple antithrombotic therapy is the independent predictor for the occurrence of major bleeding complications: Analysis of percent time in therapeutic range
-
Naruse Y, Sato A, Hoshi T, Takeyasu N, Kakefuda Y, Ishibashi M, Misaki M, Abe D, Aonuma K; Ibaraki Cardiovascular Assessment Study (ICAS) Registry. Triple antithrombotic therapy is the independent predictor for the occurrence of major bleeding complications: analysis of percent time in therapeutic range. Circ Cardiovasc Interv. 2013;6:444-451.
-
(2013)
Circ Cardiovasc Interv
, vol.6
, pp. 444-451
-
-
Naruse, Y.1
Sato, A.2
Hoshi, T.3
Takeyasu, N.4
Kakefuda, Y.5
Ishibashi, M.6
Misaki, M.7
Abe, D.8
Aonuma, K.9
-
44
-
-
79952816422
-
Meta-analysis of the combination of warfarin and dual antiplatelet therapy after coronary stenting in patients with indications for chronic oral anticoagulation
-
Gao F, Zhou YJ, Wang ZJ, Yang SW, Nie B, Liu XL, Jia de A, Yan ZX. Meta-analysis of the combination of warfarin and dual antiplatelet therapy after coronary stenting in patients with indications for chronic oral anticoagulation. Int J Cardiol. 2011;148:96-101.
-
(2011)
Int J Cardiol
, vol.148
, pp. 96-101
-
-
Gao, F.1
Zhou, Y.J.2
Wang, Z.J.3
Yang, S.W.4
Nie, B.5
Liu, X.L.6
Jia De, A.7
Yan, Z.X.8
-
45
-
-
79551592248
-
Triple therapy" rather than "triple threat": A meta-analysis of the two antithrombotic regimens after stent implantation in patients receiving long-term oral anticoagulant treatment
-
Zhao HJ, Zheng ZT, Wang ZH, Li SH, Zhang Y, Zhong M, Zhang W. "Triple therapy" rather than "triple threat": a meta-analysis of the two antithrombotic regimens after stent implantation in patients receiving long-term oral anticoagulant treatment. Chest. 2011;139:260-270.
-
(2011)
Chest
, vol.139
, pp. 260-270
-
-
Zhao, H.J.1
Zheng, Z.T.2
Wang, Z.H.3
Li, S.H.4
Zhang, Y.5
Zhong, M.6
Zhang, W.7
-
46
-
-
84855409970
-
The risk of bleeding of triple therapy with vitamin k-antagonists, aspirin and clopidogrel after coronary stent implantation: Facts and questions
-
Rubboli A. The risk of bleeding of triple therapy with vitamin K-antagonists, aspirin and clopidogrel after coronary stent implantation: facts and questions. J Geriatr Cardiol. 2011;8:207-214.
-
(2011)
J Geriatr Cardiol
, vol.8
, pp. 207-214
-
-
Rubboli, A.1
-
47
-
-
84890025521
-
Consensus and update on the definition of on-treatment platelet reactivity to adp associated with ischemia and bleeding
-
Tantry US, Bonello L, Aradi D, Price MJ, Jeong YH, Angiolillo DJ, Stone GW, Curzen N, Geisler T, Ten Berg J, Kirtane A, Siller-Matula J, Mahla E, Becker RC, Bhatt DL, Waksman R, Rao SV, Alexopoulos D, Marcucci R, Reny JL, Trenk D, Sibbing D, Gurbel PA. Consensus and update on the definition of on-treatment platelet reactivity to ADP associated with ischemia and bleeding. J Am Coll Cardiol. 2013;62:2261-2273.
-
(2013)
J Am Coll Cardiol
, vol.62
, pp. 2261-2273
-
-
Tantry, U.S.1
Bonello, L.2
Aradi, D.3
Price, M.J.4
Jeong, Y.H.5
Angiolillo, D.J.6
Stone, G.W.7
Curzen, N.8
Geisler, T.9
Ten Berg, J.10
Kirtane, A.11
Siller-Matula, J.12
Mahla, E.13
Becker, R.C.14
Bhatt, D.L.15
Waksman, R.16
Rao, S.V.17
Alexopoulos, D.18
Marcucci, R.19
Reny, J.L.20
Trenk, D.21
Sibbing, D.22
Gurbel, P.A.23
more..
-
48
-
-
74249099911
-
European society of cardiology working group on thrombosis. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting
-
Lip GY, Huber K, Andreotti F, Arnesen H, Airaksinen KJ, Cuisset T, Kirchhof P, Marin F; European Society of Cardiology Working Group on Thrombosis. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting. Thromb Haemost. 2010;103:13-28.
-
(2010)
Thromb Haemost
, vol.103
, pp. 13-28
-
-
Lip, G.Y.1
Huber, K.2
Andreotti, F.3
Arnesen, H.4
Airaksinen, K.J.5
Cuisset, T.6
Kirchhof, P.7
Marin, F.8
-
49
-
-
80053177375
-
Consensus document: Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A north-american perspective
-
Faxon DP, Eikelboom JW, Berger PB, Holmes DR, Bhatt DL, Moliterno DJ, Becker RC, Angiolillo DJ. Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective. Thromb Haemost. 2011;106:572-584.
-
(2011)
Thromb Haemost
, vol.106
, pp. 572-584
-
-
Faxon, D.P.1
Eikelboom, J.W.2
Berger, P.B.3
Holmes, D.R.4
Bhatt, D.L.5
Moliterno, D.J.6
Becker, R.C.7
Angiolillo, D.J.8
-
50
-
-
57649109102
-
Long- term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy
-
Rossini R, Musumeci G, Lettieri C, Molfese M, Mihalcsik L, Mantovani P, Sirbu V, Bass TA, Della Rovere F, Gavazzi A, Angiolillo DJ. Long- term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy. Am J Cardiol. 2008;102:1618-1623.
-
(2008)
Am J Cardiol
, vol.102
, pp. 1618-1623
-
-
Rossini, R.1
Musumeci, G.2
Lettieri, C.3
Molfese, M.4
Mihalcsik, L.5
Mantovani, P.6
Sirbu, V.7
Bass, T.A.8
Della Rovere, F.9
Gavazzi, A.10
Angiolillo, D.J.11
-
51
-
-
84875720372
-
Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: An open-label, randomised, controlled trial
-
WOEST study investigators
-
Dewilde WJ, Oirbans T, Verheugt FW, Kelder JC, De Smet BJ, Herrman JP, Adriaenssens T, Vrolix M, Heestermans AA, Vis MM, Tijsen JG, van 't Hof AW, ten Berg JM; WOEST study investigators. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet. 2013;381:1107-1115.
-
(2013)
Lancet
, vol.381
, pp. 1107-1115
-
-
Dewilde, W.J.1
Oirbans, T.2
Verheugt, F.W.3
Kelder, J.C.4
De Smet, B.J.5
Herrman, J.P.6
Adriaenssens, T.7
Vrolix, M.8
Heestermans, A.A.9
Vis, M.M.10
Tijsen, J.G.11
Van't Hof, A.W.12
Ten Berg, J.M.13
-
52
-
-
84883481368
-
Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention
-
Lamberts M, Gislason GH, Olesen JB, Kristensen SL, Schjerning Olsen AM, Mikkelsen A, Christensen CB, Lip GY, Kober L, Torp-Pedersen C, Hansen ML. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention. J Am Coll Cardiol. 2013;62:981-989.
-
(2013)
J Am Coll Cardiol
, vol.62
, pp. 981-989
-
-
Lamberts, M.1
Gislason, G.H.2
Olesen, J.B.3
Kristensen, S.L.4
Schjerning Olsen, A.M.5
Mikkelsen, A.6
Christensen, C.B.7
Lip, G.Y.8
Kober, L.9
Torp-Pedersen, C.10
Hansen, M.L.11
-
53
-
-
33748680917
-
Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: Design and rationale for the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel thrombolysis in myocardial infarction 38 (triton-timi 38
-
TRITON-TIMI 38 Investigators
-
Wiviott SD, Antman EM, Gibson CM, Montalescot G, Riesmeyer J, Weerakkody G, Winters KJ, Warmke JW, McCabe CH, Braunwald E; TRITON-TIMI 38 Investigators. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38). Am Heart J. 2006;152:627-635.
-
(2006)
Am Heart J
, vol.152
, pp. 627-635
-
-
Wiviott, S.D.1
Antman, E.M.2
Gibson, C.M.3
Montalescot, G.4
Riesmeyer, J.5
Weerakkody, G.6
Winters, K.J.7
Warmke, J.W.8
McCabe, C.H.9
Braunwald, E.10
-
54
-
-
84867177857
-
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization
-
TRILOGY ACS Investigators
-
Roe MT, Armstrong PW, Fox KA, White HD, Prabhakaran D, Goodman SG, Cornel JH, Bhatt DL, Clemmensen P, Martinez F, Ardissino D, Nicolau JC, Boden WE, Gurbel PA, Ruzyllo W, Dalby AJ, McGuire DK, Leiva- Pons JL, Parkhomenko A, Gottlieb S, Topacio GO, Hamm C, Pavlides G, Goudev AR, Oto A, Tseng CD, Merkely B, Gasparovic V, Corbalan R, Cinteza M, McLendon RC, Winters KJ, Brown EB, Lokhnygina Y, Aylward PE, Huber K, Hochman JS, Ohman EM; TRILOGY ACS Investigators. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med. 2012;367:1297-1309.
-
(2012)
N Engl J Med
, vol.367
, pp. 1297-1309
-
-
Roe, M.T.1
Armstrong, P.W.2
Fox, K.A.3
White, H.D.4
Prabhakaran, D.5
Goodman, S.G.6
Cornel, J.H.7
Bhatt, D.L.8
Clemmensen, P.9
Martinez, F.10
Ardissino, D.11
Nicolau, J.C.12
Boden, W.E.13
Gurbel, P.A.14
Ruzyllo, W.15
Dalby, A.J.16
McGuire, D.K.17
Leiva- Pons, J.L.18
Parkhomenko, A.19
Gottlieb, S.20
Topacio, G.O.21
Hamm, C.22
Pavlides, G.23
Goudev, A.R.24
Oto, A.25
Tseng, C.D.26
Merkely, B.27
Gasparovic, V.28
Corbalan, R.29
Cinteza, M.30
McLendon, R.C.31
Winters, K.J.32
Brown, E.B.33
Lokhnygina, Y.34
Aylward, P.E.35
Huber, K.36
Hochman, J.S.37
Ohman, E.M.38
more..
-
55
-
-
84877762403
-
Triple therapy with aspirin, prasugrel, and vitamin k antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation
-
Sarafoff N, Martischnig A, Wealer J, Mayer K, Mehilli J, Sibbing D, Kastrati A. Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation. J Am Coll Cardiol. 2013;61:2060-2066.
-
(2013)
J Am Coll Cardiol
, vol.61
, pp. 2060-2066
-
-
Sarafoff, N.1
Martischnig, A.2
Wealer, J.3
Mayer, K.4
Mehilli, J.5
Sibbing, D.6
Kastrati, A.7
-
57
-
-
84900459162
-
-
Brilinta (Ticagrelor). Highlights of prescribin information. Accessed November 17, 2013
-
Brilinta (Ticagrelor). Highlights of prescribin information. http://www.accessdata.fda.gov/drugsatfda-docs/label/2013/022433s008lbl.pdf. Accessed November 17, 2013.
-
-
-
-
58
-
-
70149101223
-
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
-
Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA, Freij A, Thorsén M; PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045-1057.
-
(2009)
N Engl J Med
, vol.361
, pp. 1045-1057
-
-
Wallentin, L.1
Becker, R.C.2
Budaj, A.3
Cannon, C.P.4
Emanuelsson, H.5
Held, C.6
Horrow, J.7
Husted, S.8
James, S.9
Katus, H.10
Mahaffey, K.W.11
Scirica, B.M.12
Skene, A.13
Steg, P.G.14
Storey, R.F.15
Harrington, R.A.16
Freij, A.17
Thorsén, M.18
Plato, I.19
-
59
-
-
35348879239
-
Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (petro study
-
Ezekowitz MD, Reilly PA, Nehmiz G, Simmers TA, Nagarakanti R, Parcham-Azad K, Pedersen KE, Lionetti DA, Stangier J, Wallentin L. Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study). Am J Cardiol. 2007;100:1419-1426.
-
(2007)
Am J Cardiol
, vol.100
, pp. 1419-1426
-
-
Ezekowitz, M.D.1
Reilly, P.A.2
Nehmiz, G.3
Simmers, T.A.4
Nagarakanti, R.5
Parcham-Azad, K.6
Pedersen, K.E.7
Lionetti, D.A.8
Stangier, J.9
Wallentin, L.10
-
60
-
-
84873569160
-
Concomitant use of antiplatelet therapy with dabigatran or warfarin in the randomized evaluation of long-term anticoagulation therapy (re-ly) trial
-
Dans AL, Connolly SJ, Wallentin L, Yang S, Nakamya J, Brueckmann M, Ezekowitz M, Oldgren J, Eikelboom JW, Reilly PA, Yusuf S. Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial. Circulation. 2013;127:634-640.
-
(2013)
Circulation
, vol.127
, pp. 634-640
-
-
Dans, A.L.1
Connolly, S.J.2
Wallentin, L.3
Yang, S.4
Nakamya, J.5
Brueckmann, M.6
Ezekowitz, M.7
Oldgren, J.8
Eikelboom, J.W.9
Reilly, P.A.10
Yusuf, S.11
-
61
-
-
84893502403
-
Apixaban vs. Warfarin with concomitant aspirin in patients with atrial fibrillation: Insights from the aristotle trial
-
November 18
-
Alexander JH, Lopes RD, Thomas L, Alings M, Atar D, Aylward P, Goto S, Hanna M, Huber K, Husted S, Lewis BS, McMurray JJ, Pais P, Pouleur H, Steg PG, Verheugt FW, Wojdyla DM, Granger CB, Wallentin L. Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial. Eur Heart J. November 18, 2013.
-
(2013)
Eur Heart J
-
-
Alexander, J.H.1
Lopes, R.D.2
Thomas, L.3
Alings, M.4
Atar, D.5
Aylward, P.6
Goto, S.7
Hanna, M.8
Huber, K.9
Husted, S.10
Lewis, B.S.11
McMurray, J.J.12
Pais, P.13
Pouleur, H.14
Steg, P.G.15
Verheugt, F.W.16
Wojdyla, D.M.17
Granger, C.B.18
Wallentin, L.19
-
62
-
-
80052592404
-
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
-
ROCKET AF Investigators
-
Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM; ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883-891.
-
(2011)
N Engl J Med
, vol.365
, pp. 883-891
-
-
Patel, M.R.1
Mahaffey, K.W.2
Garg, J.3
Pan, G.4
Singer, D.E.5
Hacke, W.6
Breithardt, G.7
Halperin, J.L.8
Hankey, G.J.9
Piccini, J.P.10
Becker, R.C.11
Nessel, C.C.12
Paolini, J.F.13
Berkowitz, S.D.14
Fox, K.A.15
Califf, R.M.16
-
63
-
-
80052825103
-
Apixaban versus warfarin in patients with atrial fibrillation
-
ARISTOTLE Committees and Investigators
-
Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L; ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981-992.
-
(2011)
N Engl J Med
, vol.365
, pp. 981-992
-
-
Granger, C.B.1
Alexander, J.H.2
McMurray, J.J.3
Lopes, R.D.4
Hylek, E.M.5
Hanna, M.6
Al-Khalidi, H.R.7
Ansell, J.8
Atar, D.9
Avezum, A.10
Bahit, M.C.11
Diaz, R.12
Easton, J.D.13
Ezekowitz, J.A.14
Flaker, G.15
Garcia, D.16
Geraldes, M.17
Gersh, B.J.18
Golitsyn, S.19
Goto, S.20
Hermosillo, A.G.21
Hohnloser, S.H.22
Horowitz, J.23
Mohan, P.24
Jansky, P.25
Lewis, B.S.26
Lopez-Sendon, J.L.27
Pais, P.28
Parkhomenko, A.29
Verheugt, F.W.30
Zhu, J.31
Wallentin, L.32
more..
-
64
-
-
84888362796
-
Edoxaban versus warfarin in patients with atrial fibrillation
-
ENGAGE AF-TIMI 48 Investigators
-
Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Spinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; ENGAGE AF-TIMI 48 Investigators. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369:2093-2104.
-
(2013)
N Engl J Med
, vol.369
, pp. 2093-2104
-
-
Giugliano, R.P.1
Ruff, C.T.2
Braunwald, E.3
Murphy, S.A.4
Wiviott, S.D.5
Halperin, J.L.6
Waldo, A.L.7
Ezekowitz, M.D.8
Weitz, J.I.9
Pinar, J.10
Ruzyllo, W.11
Ruda, M.12
Koretsune, Y.13
Betcher, J.14
Shi, M.15
Grip, L.T.16
Patel, S.P.17
Patel, I.18
Hanyok, J.J.19
Mercuri, M.20
Antman, E.M.21
more..
-
65
-
-
70349306707
-
Dabigatran versus warfarin in patients with atrial fibrillation
-
RE-LY Steering Committee and Investigators
-
Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139-1151.
-
(2009)
N Engl J Med
, vol.361
, pp. 1139-1151
-
-
Connolly, S.J.1
Ezekowitz, M.D.2
Yusuf, S.3
Eikelboom, J.4
Oldgren, J.5
Parekh, A.6
Pogue, J.7
Reilly, P.A.8
Themeles, E.9
Varrone, J.10
Wang, S.11
Alings, M.12
Xavier, D.13
Zhu, J.14
Diaz, R.15
Lewis, B.S.16
Darius, H.17
Diener, H.C.18
Joyner, C.D.19
Wallentin, L.20
more..
-
66
-
-
77957699729
-
Guidelines for the management of atrial fibrillation: The task force for the management of atrial fibrillation of the european society of cardiology (esc
-
European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery
-
European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31:2369-429.
-
(2010)
Eur Heart J
, vol.31
, pp. 2369-2429
-
-
Camm, A.J.1
Kirchhof, P.2
Lip, G.Y.3
Schotten, U.4
Savelieva, I.5
Ernst, S.6
Van Gelder, I.C.7
Al-Attar, N.8
Hindricks, G.9
Prendergast, B.10
Heidbuchel, H.11
Alfieri, O.12
Angelini, A.13
Atar, D.14
Colonna, P.15
De Caterina, R.16
De Sutter, J.17
Goette, A.18
Gorenek, B.19
Heldal, M.20
Hohloser, S.H.21
Kolh, P.22
Le Heuzey, J.Y.23
Ponikowski, P.24
Rutten, F.H.25
more..
-
67
-
-
0035854054
-
Validation of clinical classification schemes for predicting stroke: Results from the national registry of atrial fibrillation
-
Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285:2864-2870.
-
(2001)
JAMA
, vol.285
, pp. 2864-2870
-
-
Gage, B.F.1
Waterman, A.D.2
Shannon, W.3
Boechler, M.4
Rich, M.W.5
Radford, M.J.6
-
69
-
-
84872124721
-
Triple antithrombotic therapy following an acute coronary syndrome: Prevalence, outcomes and prognostic utility of the has-bled score
-
Smith JG, Wieloch M, Koul S, Braun OO, Lumsden J, Rydell E, Ohman J, Scherstén F, Svensson PJ, van der Pals J. Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score. Euro Intervention. 2012;8:672-678.
-
(2012)
Euro Intervention
, vol.8
, pp. 672-678
-
-
Smith, J.G.1
Wieloch, M.2
Koul, S.3
Braun, O.O.4
Lumsden, J.5
Rydell, E.6
Ohman, J.7
Scherstén, F.8
Svensson, P.J.9
Van Der Pals, J.10
-
70
-
-
84868575574
-
Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high has-bled bleeding risk score?
-
Ruiz-Nodar JM, Marin F, Roldan V, Valencia J, Manzano-Fernandez S, Caballero L, Hurtado JA, Sogorb F, Valdés M, Lip GY. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score? Circ Cardiovasc Interv. 2012;5:459-466.
-
(2012)
Circ Cardiovasc Interv
, vol.5
, pp. 459-466
-
-
Ruiz-Nodar, J.M.1
Marin, F.2
Roldan, V.3
Valencia, J.4
Manzano-Fernandez, S.5
Caballero, L.6
Hurtado, J.A.7
Sogorb, F.8
Valdés, M.9
Lip, G.Y.10
-
71
-
-
84871313726
-
Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting
-
Caballero L, Ruiz-Nodar JM, Marin F, Roldan V, Hurtado JA, Valencia J, Manzano-Fernandez S, Sogorb F, Valdes M, Lip GY. Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting. Age Ageing. 2013;42:70-75.
-
(2013)
Age Ageing.
, vol.42
, pp. 70-75
-
-
Caballero, L.1
Ruiz-Nodar, J.M.2
Marin, F.3
Roldan, V.4
Hurtado, J.A.5
Valencia, J.6
Manzano-Fernandez, S.7
Sogorb, F.8
Valdes, M.9
Lip, G.Y.10
-
72
-
-
84888135235
-
Afcas (management of patients with atrial fibrillation undergoing coronary artery stenting study group). The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: In-hospital-data from the atrial fibrillation undergoing coronary artery stenting study
-
Schlitt A, Rubboli A, Lip GY, Lahtela H, Valencia J, Karjalainen PP, Weber M, Laine M, Kirchhof P, Niemela M, Vikman S, Buerke M, Airaksinen KE; AFCAS (Management of patients with Atrial Fibrillation undergoing Coronary Artery Stenting Study Group). The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the atrial fibrillation undergoing coronary artery stenting study. Catheter Cardiovasc Interv. 2013;82:E864-E870.
-
(2013)
Catheter Cardiovasc Interv
, vol.82
-
-
Schlitt, A.1
Rubboli, A.2
Lip, G.Y.3
Lahtela, H.4
Valencia, J.5
Karjalainen, P.P.6
Weber, M.7
Laine, M.8
Kirchhof, P.9
Niemela, M.10
Vikman, S.11
Buerke, M.12
Airaksinen, K.E.13
-
73
-
-
57149140461
-
Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range
-
ACTIVE W Investigators
-
Connolly SJ, Pogue J, Eikelboom J, Flaker G, Commerford P, Franzosi MG, Healey JS, Yusuf S; ACTIVE W Investigators. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range. Circulation. 2008;118:2029-2037.
-
(2008)
Circulation
, vol.118
, pp. 2029-2037
-
-
Connolly, S.J.1
Pogue, J.2
Eikelboom, J.3
Flaker, G.4
Commerford, P.5
Franzosi, M.G.6
Healey, J.S.7
Yusuf, S.8
-
74
-
-
57149103475
-
Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: A systematic review and meta-analysis of randomized trials
-
Jolly SS, Amlani S, Hamon M, Yusuf S, Mehta SR. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials. Am Heart J. 2009;157:132-140.
-
(2009)
Am Heart J
, vol.157
, pp. 132-140
-
-
Jolly, S.S.1
Amlani, S.2
Hamon, M.3
Yusuf, S.4
Mehta, S.R.5
-
75
-
-
79955481278
-
Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (rival): A randomised, parallel group, multicentre trial
-
RIVAL trial group
-
Jolly SS, Yusuf S, Cairns J, Niemela K, Xavier D, Widimsky P, Budaj A, Niemela M, Valentin V, Lewis BS, Avezum A, Steg PG, Rao SV, Gao P, Afzal R, Joyner CD, Chrolavicius S, Mehta SR; RIVAL trial group. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet. 2011;377:1409-1420.
-
(2011)
Lancet
, vol.377
, pp. 1409-1420
-
-
Jolly, S.S.1
Yusuf, S.2
Cairns, J.3
Niemela, K.4
Xavier, D.5
Widimsky, P.6
Budaj, A.7
Niemela, M.8
Valentin, V.9
Lewis, B.S.10
Avezum, A.11
Steg, P.G.12
Rao, S.V.13
Gao, P.14
Afzal, R.15
Joyner, C.D.16
Chrolavicius, S.17
Mehta, S.R.18
-
76
-
-
33744779419
-
Percutaneous left and right heart catheterization in fully anticoagulated patients utilizing the radial artery and forearm vein: A two-center experience
-
Lo TS, Buch AN, Hall IR, Hildick-Smith DJ, Nolan J. Percutaneous left and right heart catheterization in fully anticoagulated patients utilizing the radial artery and forearm vein: a two-center experience. J Interv Cardiol. 2006;19:258-263.
-
(2006)
J Interv Cardiol
, vol.19
, pp. 258-263
-
-
Lo, T.S.1
Buch, A.N.2
Hall, I.R.3
Hildick-Smith, D.J.4
Nolan, J.5
-
77
-
-
78649407258
-
Radial versus femoral access for orally anticoagulated patients
-
Ziakas AG, Koskinas KC, Gavrilidis S, Giannoglou GD, Hadjimiltiades S, Gourassas I, Theofilogiannakos E, Economou F, Styliadis I. Radial versus femoral access for orally anticoagulated patients. Catheter Cardiovasc Interv. 2010;76:493-499.
-
(2010)
Catheter Cardiovasc Interv
, vol.76
, pp. 493-499
-
-
Ziakas, A.G.1
Koskinas, K.C.2
Gavrilidis, S.3
Giannoglou, G.D.4
Hadjimiltiades, S.5
Gourassas, I.6
Theofilogiannakos, E.7
Economou, F.8
Styliadis, I.9
-
78
-
-
84859586982
-
Stent thrombosis with drug-eluting and bare-metal stents: Evidence from a comprehensive network meta-analysis
-
Palmerini T, Biondi-Zoccai G, Della Riva D, Stettler C, Sangiorgi D, D'Ascenzo F, Kimura T, Briguori C, Sabate M, Kim HS, De Waha A, Kedhi E, Smits PC, Kaiser C, Sardella G, Marullo A, Kirtane AJ, Leon MB, Stone GW. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet. 2012;379:1393-1402.
-
(2012)
Lancet
, vol.379
, pp. 1393-1402
-
-
Palmerini, T.1
Biondi-Zoccai, G.2
Della Riva, D.3
Stettler, C.4
Sangiorgi, D.5
D'Ascenzo, F.6
Kimura, T.7
Briguori, C.8
Sabate, M.9
Kim, H.S.10
De Waha, A.11
Kedhi, E.12
Smits, P.C.13
Kaiser, C.14
Sardella, G.15
Marullo, A.16
Kirtane, A.J.17
Leon, M.B.18
Stone, G.W.19
-
79
-
-
84862128532
-
Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: A mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials
-
Bangalore S, Kumar S, Fusaro M, Amoroso N, Attubato MJ, Feit F, Bhatt DL, Slater J. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials. Circulation. 2012;125:2873-2891.
-
(2012)
Circulation
, vol.125
, pp. 2873-2891
-
-
Bangalore, S.1
Kumar, S.2
Fusaro, M.3
Amoroso, N.4
Attubato, M.J.5
Feit, F.6
Bhatt, D.L.7
Slater, J.8
-
80
-
-
84888210594
-
Stent thrombosis with drug-eluting stents: Is the paradigm shifting?
-
Palmerini T, Biondi-Zoccai G, Della Riva D, Mariani A, Genereux P, Branzi A, Stone GW. Stent thrombosis with drug-eluting stents: is the paradigm shifting? J Am Coll Cardiol. 2013;62:1915-1921.
-
(2013)
J Am Coll Cardiol
, vol.62
, pp. 1915-1921
-
-
Palmerini, T.1
Biondi-Zoccai, G.2
Della Riva, D.3
Mariani, A.4
Genereux, P.5
Branzi, A.6
Stone, G.W.7
-
81
-
-
84881086164
-
Clinical outcomes with drug-eluting and bare-metal stents in patients with st-segment elevation myocardial infarction: Evidence from a comprehensive network meta-analysis
-
Palmerini T, Biondi-Zoccai G, Della Riva D, Mariani A, Sabaté M, Valgimigli M, Frati G, Kedhi E, Smits PC, Kaiser C, Genereux P, Galatius S, Kirtane AJ, Stone GW. Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis. J Am Coll Cardiol. 2013;62:496-504.
-
(2013)
J Am Coll Cardiol
, vol.62
, pp. 496-504
-
-
Palmerini, T.1
Biondi-Zoccai, G.2
Della Riva, D.3
Mariani, A.4
Sabaté, M.5
Valgimigli, M.6
Frati, G.7
Kedhi, E.8
Smits, P.C.9
Kaiser, C.10
Genereux, P.11
Galatius, S.12
Kirtane, A.J.13
Stone, G.W.14
-
82
-
-
84867890841
-
Everolimus-eluting stent versus bare-metal stent in st-segment elevation myocardial infarction (examination): 1 year results of a randomised controlled trial
-
Sabate M, Cequier A, Iniguez A, Serra A, Hernandez-Antolin R, Mainar V, Valgimigli M, Tespili M, den Heijer P, Bethencourt A, Vazquez N, Gomez-Hospital JA, Baz JA, Martin-Yuste V, van Geuns RJ, Alfonso F, Bordes P, Tebaldi M, Masotti M, Silvestro A, Backx B, Brugaletta S, van Es GA, Serruys PW. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial. Lancet. 2012;380:1482-1490.
-
(2012)
Lancet
, vol.380
, pp. 1482-1490
-
-
Sabate, M.1
Cequier, A.2
Iniguez, A.3
Serra, A.4
Hernandez-Antolin, R.5
Mainar, V.6
Valgimigli, M.7
Tespili, M.8
Den Heijer, P.9
Bethencourt, A.10
Vazquez, N.11
Gomez-Hospital, J.A.12
Baz, J.A.13
Martin-Yuste, V.14
Van Geuns, R.J.15
Alfonso, F.16
Bordes, P.17
Tebaldi, M.18
Masotti, M.19
Silvestro, A.20
Backx, B.21
Brugaletta, S.22
Van Es, G.A.23
Serruys, P.W.24
more..
-
83
-
-
84866604206
-
Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: Mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials
-
Bangalore S, Kumar S, Fusaro M, Amoroso N, Kirtane AJ, Byrne RA, Williams DO, Slater J, Cutlip DE, Feit F. Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials. BMJ. 2012;345:e5170.
-
(2012)
BMJ
, vol.345
-
-
Bangalore, S.1
Kumar, S.2
Fusaro, M.3
Amoroso, N.4
Kirtane, A.J.5
Byrne, R.A.6
Williams, D.O.7
Slater, J.8
Cutlip, D.E.9
Feit, F.10
-
84
-
-
84890924325
-
Management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgery
-
Capodanno D, Angiolillo DJ. Management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgery. Circulation. 2013;128:2785-2798.
-
(2013)
Circulation
, vol.128
, pp. 2785-2798
-
-
Capodanno, D.1
Angiolillo, D.J.2
-
85
-
-
84900446088
-
-
Abbott's XIENCE PRIME™ and XIENCE V® Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy. Accessed December 8, 2013
-
Abbott's XIENCE PRIME™ and XIENCE V® Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy. http://www.abbott.us/news-media/pressreleases/abbotts- xience-prime-and-xience-v-drug-eluting-stents-receiveindication- in-europe-for-minimum-th.htm. Accessed December 8, 2013.
-
-
-
-
86
-
-
84900421128
-
-
Medtronic Approved to Update Resolute Integrity Stent's 'CE' Mark Labeling on Dual Antiplatelet Therapy. Accessed December 8, 2013
-
Medtronic Approved to Update Resolute Integrity Stent's 'CE' Mark Labeling on Dual Antiplatelet Therapy. http://wwwp.medtronic.com/Newsroom/ NewsReleaseDetails.do?itemId=1361899837211&lang=en-US. Accessed December 8, 2013.
-
-
-
-
87
-
-
84888209343
-
Difficult decisions with dual antiplatelet therapy: Des, stemi, unplanned treatment interruption
-
may 14-17, 2012; paris, france.
-
Palmerini T. Difficult decisions with dual antiplatelet therapy: DES, STEMI, unplanned treatment interruption. Paper presented at: EuroPCR; May 14-17, 2012; Paris, France.
-
Paper Presented At: Europcr
-
-
Palmerini, T.1
-
88
-
-
84888250961
-
The relationship between short and long-term antiplatelet therapy use and stent thrombosis following percutaneous coronary intervention with Resolute zotarolimus-eluting stent
-
March 9-11, 2013; San Francisco, CA
-
Kirtane A, Silber S, Neumann F, Serruys PW, Mauri L, Meredith I, Windecker S, Belardi J, Widimsky P, Yeung A, Saito S, Leon M. The relationship between short and long-term antiplatelet therapy use and stent thrombosis following percutaneous coronary intervention with Resolute zotarolimus-eluting stent. Paper Presented at: American College of Cardiology Scientific Sessions; March 9-11, 2013; San Francisco, CA.
-
Paper Presented at: American College of Cardiology Scientific Sessions
-
-
Kirtane, A.1
Silber, S.2
Neumann, F.3
Serruys, P.W.4
Mauri, L.5
Meredith, I.6
Windecker, S.7
Belardi, J.8
Widimsky, P.9
Yeung, A.10
Saito, S.11
Leon, M.12
-
89
-
-
84255168681
-
A new era of prospective real- world safety evaluation primary report of XIENCE V USA (XIENCE V Everolimus Eluting Coronary Stent System condition-of-approval post-market study)
-
Krucoff MW, Rutledge DR, Gruberg L, Jonnavithula L, Katopodis JN, Lombardi W, Mao VW, Sharma SK, Simonton CA, Tamboli HP, Wang J, Wilburn O, Zhao W, Sudhir K, Hermiller JB. A new era of prospective real- world safety evaluation primary report of XIENCE V USA (XIENCE V Everolimus Eluting Coronary Stent System condition-of-approval post-market study). JACC Cardiovasc Interv. 2011;4:1298-1309.
-
(2011)
JACC Cardiovasc Interv.
, vol.4
, pp. 1298-1309
-
-
Krucoff, M.W.1
Rutledge, D.R.2
Gruberg, L.3
Jonnavithula, L.4
Katopodis, J.N.5
Lombardi, W.6
Mao, V.W.7
Sharma, S.K.8
Simonton, C.A.9
Tamboli, H.P.10
Wang, J.11
Wilburn, O.12
Zhao, W.13
Sudhir, K.14
Hermiller, J.B.15
-
90
-
-
84890373385
-
Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: The optimize randomized trial
-
OPTIMIZE Trial Investigators
-
Feres F, Costa RA, Abizaid A, Leon MB, Marin-Neto JA, Botelho RV, King SB III, Negoita M, Liu M, de Paula JE, Mangione JA, Meireles GX, Castello HJ Jr., Nicolela EL Jr., Perin MA, Devito FS, Labrunie A, Salvadori D Jr., Gusmao M, Staico R, Costa JR Jr., de Castro JP, Abizaid AS, Bhatt DL; OPTIMIZE Trial Investigators. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial. JAMA. 2013;310:2510-2522.
-
(2013)
JAMA
, vol.310
, pp. 2510-2522
-
-
Feres, F.1
Costa, R.A.2
Abizaid, A.3
Leon, M.B.4
Marin-Neto, J.A.5
Botelho, R.V.6
King III, S.B.7
Negoita, M.8
Liu, M.9
De Paula, J.E.10
Mangione, J.A.11
Meireles, G.X.12
Castello Jr., H.J.13
Nicolela Jr., E.L.14
Perin, M.A.15
Devito, F.S.16
Labrunie, A.17
Salvadori Jr., D.18
Gusmao, M.19
Staico, R.20
Costa Jr., J.R.21
De Castro, J.P.22
Abizaid, A.S.23
Bhatt, D.L.24
more..
-
91
-
-
84890615369
-
Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: Results from a registry of 18,334 patients
-
Tada T, Byrne RA, Simunovic I, King LA, Cassese S, Joner M, Fusaro M, Schneider S, Schulz S, Ibrahim T, Ott I, Massberg S, Laugwitz KL, Kastrati A. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients. JACC Cardiovasc Interv. 2013;6:1267-1274.
-
(2013)
JACC Cardiovasc Interv
, vol.6
, pp. 1267-1274
-
-
Tada, T.1
Byrne, R.A.2
Simunovic, I.3
King, L.A.4
Cassese, S.5
Joner, M.6
Fusaro, M.7
Schneider, S.8
Schulz, S.9
Ibrahim, T.10
Ott, I.11
Massberg, S.12
Laugwitz, K.L.13
Kastrati, A.14
-
92
-
-
84885441282
-
Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents
-
Hawn MT, Graham LA, Richman JS, Itani KM, Henderson WG, Maddox TM. Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. JAMA. 2013;310:1462-1472.
-
(2013)
JAMA
, vol.310
, pp. 1462-1472
-
-
Hawn, M.T.1
Graham, L.A.2
Richman, J.S.3
Itani, K.M.4
Henderson, W.G.5
Maddox, T.M.6
-
93
-
-
77956167248
-
Coronary stents: Looking forward
-
Garg S, Serruys PW. Coronary stents: looking forward. J Am Coll Cardiol. 2010;56(10 suppl):S43-S78.
-
(2010)
J Am Coll Cardiol
, vol.56
, Issue.10 SUPPL.
-
-
Garg, S.1
Serruys, P.W.2
-
94
-
-
84861733232
-
Afcas (management of patients with atrial fibrillation undergoing coronary artery stenting) study group. Heparin bridging vs. Uninterrupted oral anticoagulation in patients with atrial fibrillation undergoing coronary artery stenting. Results from the afcas registry
-
Lahtela H, Rubboli A, Schlitt A, Karjalainen PP, Niemela M, Vikman S, Puurunen M, Weber M, Valencia J, Biancari F, Lip GY, Airaksinen KE; AFCAS (Management of patients with Atrial Fibrillation undergoing Coronary Artery Stenting) study group. Heparin bridging vs. uninterrupted oral anticoagulation in patients with Atrial Fibrillation undergoing Coronary Artery Stenting. Results from the AFCAS registry. Circ J. 2012;76:1363-1368.
-
(2012)
Circ J
, vol.76
, pp. 1363-1368
-
-
Lahtela, H.1
Rubboli, A.2
Schlitt, A.3
Karjalainen, P.P.4
Niemela, M.5
Vikman, S.6
Puurunen, M.7
Weber, M.8
Valencia, J.9
Biancari, F.10
Lip, G.Y.11
Airaksinen, K.E.12
-
95
-
-
3042782723
-
Enoxaparin vs unfractionated heparin in high-risk patients with non-st-segment elevation acute coronary syndromes managed with an intended early invasive strategy: Primary results of the synergy randomized trial
-
SYNERGY Trial Investigators
-
Ferguson JJ, Califf RM, Antman EM, Cohen M, Grines CL, Goodman S, Kereiakes DJ, Langer A, Mahaffey KW, Nessel CC, Armstrong PW, Avezum A, Aylward P, Becker RC, Biasucci L, Borzak S, Col J, Frey MJ, Fry E, Gulba DC, Guneri S, Gurfinkel E, Harrington R, Hochman JS, Kleiman NS, Leon MB, Lopez-Sendon JL, Pepine CJ, Ruzyllo W, Steinhubl SR, Teirstein PS, Toro-Figueroa L, White H; SYNERGY Trial Investigators. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA. 2004;292:45-54.
-
(2004)
JAMA
, vol.292
, pp. 45-54
-
-
Ferguson, J.J.1
Califf, R.M.2
Antman, E.M.3
Cohen, M.4
Grines, C.L.5
Goodman, S.6
Kereiakes, D.J.7
Langer, A.8
Mahaffey, K.W.9
Nessel, C.C.10
Armstrong, P.W.11
Avezum, A.12
Aylward, P.13
Becker, R.C.14
Biasucci, L.15
Borzak, S.16
Col, J.17
Frey, M.J.18
Fry, E.19
Gulba, D.C.20
Guneri, S.21
Gurfinkel, E.22
Harrington, R.23
Hochman, J.S.24
Kleiman, N.S.25
Leon, M.B.26
Lopez-Sendon, J.L.27
Pepine, C.J.28
Ruzyllo, W.29
Steinhubl, S.R.30
Teirstein, P.S.31
Toro-Figueroa, L.32
White, H.33
more..
-
96
-
-
67650517543
-
Adding intravenous unfractionated heparin to standard enoxaparin causes excessive anticoagulation not detected by activated clotting time: Results of the stack-on to enoxaparin (stackenox) study
-
Drouet L, Bal dit Sollier C, Martin J. Adding intravenous unfractionated heparin to standard enoxaparin causes excessive anticoagulation not detected by activated clotting time: results of the STACK-on to ENOXaparin (STACKENOX) study. Am Heart J. 2009;158:177-184.
-
(2009)
Am Heart J
, vol.158
, pp. 177-184
-
-
Drouet, L.1
Bal Dit Sollier, C.2
Martin, J.3
-
97
-
-
3843060250
-
Long-term efficacy of bivalirudin and provisional glycoprotein iib/iiia blockade vs heparin and planned glycoprotein iib/iiia blockade during percutaneous coronary revascularization: Replace-2 randomized trial
-
REPLACE-2 Investigators
-
Lincoff AM, Kleiman NS, Kereiakes DJ, Feit F, Bittl JA, Jackman JD, Sarembock IJ, Cohen DJ, Spriggs D, Ebrahimi R, Keren G, Carr J, Cohen EA, Betriu A, Desmet W, Rutsch W, Wilcox RG, de Feyter PJ, Vahanian A, Topol EJ; REPLACE-2 Investigators. Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. JAMA. 2004;292:696-703.
-
(2004)
JAMA
, vol.292
, pp. 696-703
-
-
Lincoff, A.M.1
Kleiman, N.S.2
Kereiakes, D.J.3
Feit, F.4
Bittl, J.A.5
Jackman, J.D.6
Sarembock, I.J.7
Cohen, D.J.8
Spriggs, D.9
Ebrahimi, R.10
Keren, G.11
Carr, J.12
Cohen, E.A.13
Betriu, A.14
Desmet, W.15
Rutsch, W.16
Wilcox, R.G.17
De Feyter, P.J.18
Vahanian, A.19
Topol, E.J.20
more..
-
98
-
-
84868657039
-
Bivalirudin versus heparin plus a glycoprotein iib/iiia inhibitor in patients with non-st-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: Pooled analysis from the acuity and isar-react 4 trials
-
Ndrepepa G, Neumann FJ, Deliargyris EN, Mehran R, Mehilli J, Ferenc M, Schulz S, Schomig A, Kastrati A, Stone GW. Bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: pooled analysis from the ACUITY and ISAR-REACT 4 trials. Circ Cardiovasc Interv. 2012;5:705-712.
-
(2012)
Circ Cardiovasc Interv
, vol.5
, pp. 705-712
-
-
Ndrepepa, G.1
Neumann, F.J.2
Deliargyris, E.N.3
Mehran, R.4
Mehilli, J.5
Ferenc, M.6
Schulz, S.7
Schomig, A.8
Kastrati, A.9
Stone, G.W.10
-
99
-
-
79959696572
-
Heparin plus a glycoprotein iib/iiia inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (horizons-ami): Final 3-year results from a multicentre, randomised controlled trial
-
HORIZONS-AMI Trial Investigators
-
Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Fahy M, Parise H, Mehran R; HORIZONS-AMI Trial Investigators. Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial. Lancet. 2011;377:2193-2204.
-
(2011)
Lancet
, vol.377
, pp. 2193-2204
-
-
Stone, G.W.1
Witzenbichler, B.2
Guagliumi, G.3
Peruga, J.Z.4
Brodie, B.R.5
Dudek, D.6
Kornowski, R.7
Hartmann, F.8
Gersh, B.J.9
Pocock, S.J.10
Dangas, G.11
Wong, S.C.12
Fahy, M.13
Parise, H.14
Mehran, R.15
-
100
-
-
84864400448
-
Meta-analysis comparing bivalirudin versus heparin monotherapy on ischemic and bleeding outcomes after percutaneous coronary intervention
-
Bertrand OF, Jolly SS, Rao SV, Patel T, Belle L, Bernat I, Parodi G, Costerousse O, Mann T. Meta-analysis comparing bivalirudin versus heparin monotherapy on ischemic and bleeding outcomes after percutaneous coronary intervention. Am J Cardiol. 2012;110:599-606.
-
(2012)
Am J Cardiol
, vol.110
, pp. 599-606
-
-
Bertrand, O.F.1
Jolly, S.S.2
Rao, S.V.3
Patel, T.4
Belle, L.5
Bernat, I.6
Parodi, G.7
Costerousse, O.8
Mann, T.9
-
101
-
-
84878755472
-
Current status and ongoing development of reversing agents for novel oral anticoagulants (noacs
-
Capodanno D, Giacchi G, Tamburino C. Current status and ongoing development of reversing agents for novel oral anticoagulants (NOACs). Recent Pat Cardiovasc Drug Discov. 2013;8:2-9.
-
(2013)
Recent Pat Cardiovasc Drug Discov
, vol.8
, pp. 2-9
-
-
Capodanno, D.1
Giacchi, G.2
Tamburino, C.3
-
103
-
-
84882267105
-
Dabigatran bleed risk with closed head injuries: Are we prepared?
-
Parra MW, Zucker L, Johnson ES, Gullett D, Avila C, Wichner ZA, Kokaram CR. Dabigatran bleed risk with closed head injuries: are we prepared? J Neurosurg. 2013;119:760-765.
-
(2013)
J Neurosurg.
, vol.119
, pp. 760-765
-
-
Parra, M.W.1
Zucker, L.2
Johnson, E.S.3
Gullett, D.4
Avila, C.5
Wichner, Z.A.6
Kokaram, C.R.7
-
104
-
-
84873126984
-
2013 Accf/aha guideline for the management of st-elevation myocardial infarction: A report of the american college of cardiology foundation/american heart association task force on practice guidelines
-
American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
-
O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr., Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX, Anderson JL, Jacobs AK, Halperin JL, Albert NM, Brindis RG, Creager MA, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Kushner FG, Ohman EM, Stevenson WG, Yancy CW; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:e362-e425.
-
(2013)
Circulation
, vol.127
-
-
O'Gara, P.T.1
Kushner, F.G.2
Ascheim, D.D.3
Casey Jr., D.E.4
Chung, M.K.5
De Lemos, J.A.6
Ettinger, S.M.7
Fang, J.C.8
Fesmire, F.M.9
Franklin, B.A.10
Granger, C.B.11
Krumholz, H.M.12
Linderbaum, J.A.13
Morrow, D.A.14
Newby, L.K.15
Ornato, J.P.16
Ou, N.17
Radford, M.J.18
Tamis-Holland, J.E.19
Tommaso, C.L.20
Tracy, C.M.21
Woo, Y.J.22
Zhao, D.X.23
Anderson, J.L.24
Jacobs, A.K.25
Halperin, J.L.26
Albert, N.M.27
Brindis, R.G.28
Creager, M.A.29
DeMets, D.30
Guyton, R.A.31
Hochman, J.S.32
Kovacs, R.J.33
Kushner, F.G.34
Ohman, E.M.35
Stevenson, W.G.36
Yancy, C.W.37
more..
-
105
-
-
84866732231
-
Esc guidelines for the management of acute myocardial infarction in patients presenting with st-segment elevation
-
Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC
-
Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van 't Hof A, Widimsky P, Zahger D. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33:2569-619.
-
(2012)
Eur Heart J
, vol.33
, pp. 2569-2619
-
-
Steg, P.G.1
James, S.K.2
Atar, D.3
Badano, L.P.4
Blomstrom-Lundqvist, C.5
Borger, M.A.6
Di Mario, C.7
Dickstein, K.8
Ducrocq, G.9
Fernandez-Aviles, F.10
Gershlick, A.H.11
Giannuzzi, P.12
Halvorsen, S.13
Huber, K.14
Juni, P.15
Kastrati, A.16
Knuuti, J.17
Lenzen, M.J.18
Mahaffey, K.W.19
Valgimigli, M.20
Van 't Hof, A.21
Widimsky, P.22
Zahger, D.23
more..
-
106
-
-
78650739879
-
2008 Expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and nsaid use: A report of the
-
ACCF/ACG/AHA. ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA American College of Cardiology Foundation Task Force on Expert Consensus Documents
-
Abraham NS, Hlatky MA, Antman EM, Bhatt DL, Bjorkman DJ, Clark CB, Furberg CD, Johnson DA, Kahi CJ, Laine L, Mahaffey KW, Quigley EM, Scheiman J, Sperling LS, Tomaselli GF; ACCF/ACG/AHA. ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation. 2010;122:2619-2633.
-
(2010)
Circulation
, vol.122
, pp. 2619-2633
-
-
Abraham, N.S.1
Hlatky, M.A.2
Antman, E.M.3
Bhatt, D.L.4
Bjorkman, D.J.5
Clark, C.B.6
Furberg, C.D.7
Johnson, D.A.8
Kahi, C.J.9
Laine, L.10
Mahaffey, K.W.11
Quigley, E.M.12
Scheiman, J.13
Sperling, L.S.14
Tomaselli, G.F.15
-
107
-
-
84875215590
-
-
Accessed December 6, 2013
-
Plavix Prescribing Information. http://products.sanofi.us/plavix/plavix. html. Accessed December 6, 2013.
-
Plavix Prescribing Information
-
-
-
108
-
-
69249206873
-
Antiplatelet therapy: Clopidogrel plus ppis - A dangerous combination?
-
Ferreiro JL, Angiolillo DJ. Antiplatelet therapy: Clopidogrel plus PPIs-a dangerous combination? Nat Rev Cardiol. 2009;6:392-394.
-
(2009)
Nat Rev Cardiol
, vol.6
, pp. 392-394
-
-
Ferreiro, J.L.1
Angiolillo, D.J.2
-
109
-
-
78149487926
-
Clopidogrel with or without omeprazole in coronary artery disease
-
Bhatt DL, Cryer BL, Contant CF, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, Scirica BM, Murphy SA, Cannon CP; COGENT Investigators. Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med. 2010;363:1909-1917.
-
(2010)
N Engl J Med
, vol.363
, pp. 1909-1917
-
-
Bhatt, D.L.1
Cryer, B.L.2
Contant, C.F.3
Cohen, M.4
Lanas, A.5
Schnitzer, T.J.6
Shook, T.L.7
Lapuerta, P.8
Goldsmith, M.A.9
Laine, L.10
Scirica, B.M.11
Murphy, S.A.12
Cannon, C.P.13
Cogent, I.14
-
110
-
-
78650517232
-
Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects: Randomized, placebo-controlled, crossover comparison studies
-
Angiolillo DJ, Gibson CM, Cheng S, Ollier C, Nicolas O, Bergougnan L, Perrin L, LaCreta FP, Hurbin F, Dubar M. Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects: randomized, placebo-controlled, crossover comparison studies. Clin Pharmacol Ther. 2011;89:65-74.
-
(2011)
Clin Pharmacol Ther
, vol.89
, pp. 65-74
-
-
Angiolillo, D.J.1
Gibson, C.M.2
Cheng, S.3
Ollier, C.4
Nicolas, O.5
Bergougnan, L.6
Perrin, L.7
LaCreta, F.P.8
Hurbin, F.9
Dubar, M.10
-
111
-
-
84859138447
-
A randomized, 2-period, crossover design study to assess the effects of dexlansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers
-
Frelinger AL III, Lee RD, Mulford DJ, Wu J, Nudurupati S, Nigam A, Brooks JK, Bhatt DL, Michelson AD. A randomized, 2-period, crossover design study to assess the effects of dexlansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers. J Am Coll Cardiol. 2012;59:1304-1311.
-
(2012)
J Am Coll Cardiol
, vol.59
, pp. 1304-1311
-
-
Frelinger III, A.L.1
Lee, R.D.2
Mulford, D.J.3
Wu, J.4
Nudurupati, S.5
Nigam, A.6
Brooks, J.K.7
Bhatt, D.L.8
Michelson, A.D.9
-
112
-
-
78649367456
-
Impact of red blood cell transfusion on platelet activation and aggregation in healthy volunteers: Results of the transfusion study
-
Silvain J, Pena A, Cayla G, Brieger D, Bellemain-Appaix A, Chastre T, Vignalou JB, Beygui F, Barthelemy O, Collet JP, Montalescot G. Impact of red blood cell transfusion on platelet activation and aggregation in healthy volunteers: results of the TRANSFUSION study. Eur Heart J. 2010;31:2816-2821.
-
(2010)
Eur Heart J
, vol.31
, pp. 2816-2821
-
-
Silvain, J.1
Pena, A.2
Cayla, G.3
Brieger, D.4
Bellemain-Appaix, A.5
Chastre, T.6
Vignalou, J.B.7
Beygui, F.8
Barthelemy, O.9
Collet, J.P.10
Montalescot, G.11
-
113
-
-
84873034413
-
Platelet function normalization after a prasugrel loading-dose: Time-dependent effect of platelet supplementation
-
Zafar MU, Santos-Gallego C, Vorchheimer DA, Viles-Gonzalez JF, Elmariah S, Giannarelli C, Sartori S, Small DS, Jakubowski JA, Fuster V, Badimon JJ. Platelet function normalization after a prasugrel loading-dose: time-dependent effect of platelet supplementation. J Thromb Haemost. 2013;11:100-106.
-
(2013)
J Thromb Haemost
, vol.11
, pp. 100-106
-
-
Zafar, M.U.1
Santos-Gallego, C.2
Vorchheimer, D.A.3
Viles-Gonzalez, J.F.4
Elmariah, S.5
Giannarelli, C.6
Sartori, S.7
Small, D.S.8
Jakubowski, J.A.9
Fuster, V.10
Badimon, J.J.11
-
115
-
-
23644443663
-
Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: Meta-analysis with estimates of risk and benefit
-
Rothberg MB, Celestin C, Fiore LD, Lawler E, Cook JR. Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit. Ann Intern Med. 2005;143:241-250.
-
(2005)
Ann Intern Med
, vol.143
, pp. 241-250
-
-
Rothberg, M.B.1
Celestin, C.2
Fiore, L.D.3
Lawler, E.4
Cook, J.R.5
-
116
-
-
0041829444
-
Oral ximelagatran for secondary prophylaxis after myocardial infarction: The esteem randomised controlled trial
-
Wallentin L, Wilcox RG, Weaver WD, Emanuelsson H, Goodvin A, Nystrom P, Bylock A; ESTEEM Investigators. Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial. Lancet. 2003;362:789-797.
-
(2003)
Lancet
, vol.362
, pp. 789-797
-
-
Wallentin, L.1
Wilcox, R.G.2
Weaver, W.D.3
Emanuelsson, H.4
Goodvin, A.5
Nystrom, P.6
Bylock, A.7
Esteem, I.8
-
117
-
-
80052232522
-
Dabigatran vs. Placebo in patients with acute coronary syndromes on dual antiplatelet therapy: A randomized, double-blind, phase ii trial
-
RE-DEEM Investigators
-
Oldgren J, Budaj A, Granger CB, Khder Y, Roberts J, Siegbahn A, Tijssen JG, Van De Werf F, Wallentin L; RE-DEEM Investigators. Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial. Eur Heart J. 2011;32:2781-2789.
-
(2011)
Eur Heart J
, vol.32
, pp. 2781-2789
-
-
Oldgren, J.1
Budaj, A.2
Granger, C.B.3
Khder, Y.4
Roberts, J.5
Siegbahn, A.6
Tijssen, J.G.7
Van De Werf, F.8
Wallentin, L.9
-
118
-
-
80054733922
-
Ruby-1: A randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor xa inhibitor darexaban (ym150) following acute coronary syndrome
-
RUBY-1 Investigators
-
Steg PG, Mehta SR, Jukema JW, Lip GY, Gibson CM, Kovar F, Kala P, Garcia-Hernandez A, Renfurm RW, Granger CB; RUBY-1 Investigators. RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome. Eur Heart J. 2011;32:2541-2554.
-
(2011)
Eur Heart J
, vol.32
, pp. 2541-2554
-
-
Steg, P.G.1
Mehta, S.R.2
Jukema, J.W.3
Lip, G.Y.4
Gibson, C.M.5
Kovar, F.6
Kala, P.7
Garcia-Hernandez, A.8
Renfurm, R.W.9
Granger, C.B.10
-
119
-
-
80052162121
-
Apixaban with antiplatelet therapy after acute coronary syndrome
-
APPRAISE-2 Investigators
-
Alexander JH, Lopes RD, James S, Kilaru R, He Y, Mohan P, Bhatt DL, Goodman S, Verheugt FW, Flather M, Huber K, Liaw D, Husted SE, Lopez-Sendon J, De Caterina R, Jansky P, Darius H, Vinereanu D, Cornel JH, Cools F, Atar D, Leiva-Pons JL, Keltai M, Ogawa H, Pais P, Parkhomenko A, Ruzyllo W, Diaz R, White H, Ruda M, Geraldes M, Lawrence J, Harrington RA, Wallentin L; APPRAISE-2 Investigators. Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med. 2011;365:699-708.
-
(2011)
N Engl J Med
, vol.365
, pp. 699-708
-
-
Alexander, J.H.1
Lopes, R.D.2
James, S.3
Kilaru, R.4
He, Y.5
Mohan, P.6
Bhatt, D.L.7
Goodman, S.8
Verheugt, F.W.9
Flather, M.10
Huber, K.11
Liaw, D.12
Husted, S.E.13
Lopez-Sendon, J.14
De Caterina, R.15
Jansky, P.16
Darius, H.17
Vinereanu, D.18
Cornel, J.H.19
Cools, F.20
Atar, D.21
Leiva-Pons, J.L.22
Keltai, M.23
Ogawa, H.24
Pais, P.25
Parkhomenko, A.26
Ruzyllo, W.27
Diaz, R.28
White, H.29
Ruda, M.30
Geraldes, M.31
Lawrence, J.32
Harrington, R.A.33
Wallentin, L.34
more..
-
120
-
-
84862907587
-
Atlas acs 2-timi 51 investigators. Rivaroxaban in patients with a recent acute coronary syndrome
-
Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Bode C, Burton P, Cohen M, Cook-Bruns N, Fox KA, Goto S, Murphy SA, Plotnikov AN, Schneider D, Sun X, Verheugt FW, Gibson CM; ATLAS ACS 2-TIMI 51 Investigators. Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med. 2012;366:9-19.
-
(2012)
N Engl J Med
, vol.366
, pp. 9-19
-
-
Mega, J.L.1
Braunwald, E.2
Wiviott, S.D.3
Bassand, J.P.4
Bhatt, D.L.5
Bode, C.6
Burton, P.7
Cohen, M.8
Cook-Bruns, N.9
Fox, K.A.10
Goto, S.11
Murphy, S.A.12
Plotnikov, A.N.13
Schneider, D.14
Sun, X.15
Verheugt, F.W.16
Gibson, C.M.17
|